Target price | $4.90 |
Course | $1.00 |
Price potential |
392.50%
register free of charge
|
Number of estimates | 6 |
6 Analysts have issued a price target Oncolytics Biotech Inc. 2025 .
The average Oncolytics Biotech Inc. target price is $4.90.
This is
392.50%
register free of charge
$6.60
563.42%
register free of charge
$2.20
120.58%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend Oncolytics Biotech Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst estimates: Analysts believe that the Oncolytics Biotech Inc. share has an average upside potential 2025 of
392.50%
register free of charge
|
Dec '23 |
2024 Forecast |
|
---|---|---|
Earnings per share $ | -0.30 | -0.30 |
9.09% | 0.00% | |
P/E ratio | negative | |
EV/Sales | 62.00 |
4 Analysts have issued a Oncolytics Biotech Inc. forecast for earnings per share. The average Oncolytics Biotech Inc. <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Oncolytics Biotech Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.